Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
ASSETS
Current assets
Cash
Prepaid expenses
Total Current Assets
Investments held in trust account
TOTAL ASSETS
LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS’ DEFICIT
Current liabilities:
Accrued expenses
Amount due to a related party
Due to related party
Related Party
Total due to related party
Working capital loan payable, related party
Extension loan payable, related party
Related Party
Total extension loan payable, related party
Other payable
Total Current Liabilities
Deferred Underwriting Compensation
TOTAL LIABILITIES
Ordinary shares subject to possible redemption, 210,052 and 1,550,297 shares issued and outstanding at redemption value as of September 30, 2024 and December 31, 2023, respectively
Shareholders’ deficit:
Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 1,768,000 shares issued and outstanding (excluding 210,052 and 1,550,297 shares subject to redemption as of September 30, 2024 and December 31, 2023, respectively)
Additional paid-in capital
Accumulated deficit
Total Shareholders’ Deficit
TOTAL LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS’ DEFICIT

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support